Literature DB >> 8232940

Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients.

S DiDonato1, M Zeviani, P Giovannini, N Savarese, M Rimoldi, C Mariotti, F Girotti, T Caraceni.   

Abstract

There are several reports of a defect of complex I in the substantia nigra (SN) of Parkinson's disease (PD) patients. To evaluate whether this is specific to dopaminergic neurons or the phenotypically relevant consequence of a widespread failure of the mitochondrial oxidative phosphorylation (OXPHOS) system, we measured respiratory enzyme activities in muscle homogenates from 16 PD patients and eight age-matched controls, and in muscle isolated mitochondria of six PD patients and six age-matched controls. We found no difference between the PD and control groups. In addition, we detected, by polymerase chain reaction, the mitochondrial DNA (mtDNA) "common deletion" (CD) in muscle specimens of 14 of 17 PD patients, but we obtained similar results in age-matched controls. In both groups, the amount of CD-specific deleted (delta) mtDNA ranged from 0.0% to 0.1%. Our data suggest that PD cannot be attributed to a multisystem decline of mitochondrial OXPHOS, and that lesions of muscle mtDNA in PD are likely due to normal aging. However, there was a remarkable accumulation of delta mtDNA in the SN of a PD patient and an age-matched control, suggesting that the SN is exquisitely sensitive to age-dependent damage of the mitochondrial genome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232940     DOI: 10.1212/wnl.43.11.2262

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Exercise test in Parkinson's disease.

Authors:  I Reuter; M Engelhardt; J Freiwaldt; H Baas
Journal:  Clin Auton Res       Date:  1999-06       Impact factor: 4.435

2.  Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion.

Authors:  A Barrientos; J Casademont; A Saiz; F Cardellach; V Volpini; A Solans; E Tolosa; A Urbano-Marquez; X Estivill; V Nunes
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

Review 3.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 4.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

Review 5.  Early detection of Parkinson's disease. Implications for treatment.

Authors:  R Di Paola; R J Uitti
Journal:  Drugs Aging       Date:  1996-09       Impact factor: 3.923

6.  Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease.

Authors:  M Gold; R A Hauser; M F Chen
Journal:  Metab Brain Dis       Date:  1998-03       Impact factor: 3.584

7.  A nuclear defect in the 4p16 region predisposes to multiple mitochondrial DNA deletions in families with Wolfram syndrome.

Authors:  A Barrientos; V Volpini; J Casademont; D Genís; J M Manzanares; I Ferrer; J Corral; F Cardellach; A Urbano-Márquez; X Estivill; V Nunes
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

8.  Niacin metabolism and Parkinson's disease.

Authors:  Tetsuhito Fukushima
Journal:  Environ Health Prev Med       Date:  2005-01       Impact factor: 3.674

9.  Oxidative stress in skin fibroblasts cultures from patients with Parkinson's disease.

Authors:  Pilar del Hoyo; Alberto García-Redondo; Fernando de Bustos; José Antonio Molina; Youssef Sayed; Hortensia Alonso-Navarro; Luis Caballero; Joaquín Arenas; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  BMC Neurol       Date:  2010-10-19       Impact factor: 2.474

Review 10.  The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.

Authors:  Giacomo Monzio Compagnoni; Alessio Di Fonzo; Stefania Corti; Giacomo P Comi; Nereo Bresolin; Eliezer Masliah
Journal:  Mol Neurobiol       Date:  2020-05-22       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.